[ad_1] Eli Lilly bets $409M for AI-focused drug discovery [ad_2] Source: Seekingalpha
Browsing: drug
[ad_1] Lisata jumps on FDA orphan drug status for bile duct cancer drug [ad_2] Source: Seekingalpha
[ad_1] Ascendis raised to outperform by Oppenheimer ahead of drug launch [ad_2] Source: Seekingalpha
[ad_1] Travere gains on full FDA approval for kidney drug Filspari [ad_2] Source: Seekingalpha
[ad_1] Psyence Biomedical to acquire drug developer Clairvoyant [ad_2] Source: Seekingalpha
[ad_1] Stifel starts ORIC at purchase, cites prostate cancer drug candidate [ad_2] Source: Seekingalpha
[ad_1] Merck, Daiichi post mid-stage data for novel lung cancer drug [ad_2] Source: Seekingalpha
[ad_1] Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket [ad_2] Source: Seekingalpha
[ad_1] Eli Lilly bets $409M for AI-focused drug discovery [ad_2] Source: Seekingalpha
[ad_1] Lisata jumps on FDA orphan drug status for liver cancer drug [ad_2] Source: Seekingalpha